How Effective and What is the Cost and Cost Benefit of Sorafenib?

Executive Summary  Sorafenib is taken as a treatment for lung cancer. We have never seen a cost-benefit analysis for this drug, so we have done that in this article. Introduction Sorafenib is a drug that interferes with the spread of cancer. Wait One Second… Why is The Article Not Viewable? You are seeing this text…

How Effective and What is the Cost and Cost Benefit of Gefitinib?

Executive Summary  Gefitinib is taken as a treatment for lung cancer. We have never seen a cost-benefit analysis for this drug, so we have done that in this article. Introduction Gefitinib is a drug that interferes with the spread of cancer. Wait One Second… Why is The Article Not Viewable? You are seeing this text…

How Effective and What is the Cost and Cost Benefit of Abiraterone?

Executive Summary  Abiraterone is taken as a treatment for prostate cancer. We have never seen a cost-benefit analysis for this drug, so we have done that in this article. Introduction Abiraterone is a drug that adjusts male hormones to address cancer of the prostate. Wait One Second… Why is The Article Not Viewable? You are…

How Effective and What is the Cost and Cost Benefit of Xeloda?

Executive Summary  Xeloda is taken as a treatment for breast and colorectal cancer. We have never seen a cost-benefit analysis for this drug, so we have done that in this article. Introduction As you can read in the articles on this site on Chemotherapy, chemotherapy is an extremely overrated treatment. Wait One Second… Why is…

What is the Correct Ivermectin Dosage to Treat Cancer in Dogs and Cats?

 Executive Summary Ivermectin is not only effective against cancer in humans, but it is also effective against cancer in many pets. We cover the dosage question for pets in this article. Article Summary This article covers the studies into the use of Ivermectin against cancer in animals, the problem with the general shortage of information…

The City of Hope Admits to Testing Ivemectin Versus Cancer

 Executive Summary The medical establishment is very much opposed to using Ivermectin to treat cancer. This is why it is so surprising to see an article at the City of Hope cancer center about using Ivermectin for this purpose. Introduction After so many medical authorities advising against Ivermectin even for things other than cancer and…

The Relevance of Ivermectin Not Interfering With Conventional Cancer Treatments

 Executive Summary Frequently subscribers think they need to work with their oncologists regarding using Ivermectin. This article will address why this is not the case from multiple dimensions. Introduction There are several important features to understand regarding the lack of negative interaction between Ivermectin and conventional cancer treatments and what this means for using Ivermectin….

The Medical Establishment Calls The Benefits of Not Using Chemotherapy Customized Treatment

Executive Summary Medicine can say that a treatment is effective, only to backtrack on what they said before, and still manage to present their errors as a massive success story. Introduction It never ceases to amaze me how the medical establishment can cast the ineffective treatments they change course on as success stories. One example…

How Many People Died From Covid Versus What Was Reported?

Executive Summary Information continues to stream in that shows the health authorities, and others exaggerated the deaths from covid. Introduction Previously, I covered in the article Understanding the PCR Test and How There Was Never a Reliable Test for Covid how the tests for Covid were deliberately designed to show false positives. I have debated…

How The Medical Establishment Lies About Statin Side Effects

Executive Summary It is amazing to read the side effects of statins from first-person accounts and then to see the medical establishment pretend that these side effects are unrelated to statin use. Introduction How much can the medical and establishment media lie about side effects? As you will see in this article, the issue of…